bims-spamet Biomed News
on Spatial metabolomics of T cells
Issue of 2026–11–08
eight papers selected by
Peio Azcoaga, Katholieke Universiteit te Leuven



  1. Int J Hematol. 2026 Nov 02.
      T cell exhaustion is an antigen-driven differentiation program originally defined in chronic infection and now recognized as a major determinant of antitumor immunity. It is best characterized in CD8+ T cells, in which chronic stimulation induces functional impairment, inhibitory-receptor expression, transcriptional and epigenetic reprogramming, and metabolic dysfunction. Exhausted T cells are heterogeneous, ranging from progenitor populations that retain proliferative capacity and responsiveness to programmed cell death protein 1 (PD-1) blockade to terminally exhausted states with limited reversibility. In solid tumors, immune checkpoint blockade acts largely through tumor-reactive exhausted CD8+ T cells. In classic Hodgkin lymphoma, frequent loss of major histocompatibility complex (MHC) class I and retention of MHC class II suggest a greater contribution of cytotoxic CD4+ T cells, and PD-1 blockade may reinvigorate dysfunctional or exhaustion-like CD4+ T cells. Exhaustion also affects chimeric antigen receptor (CAR) T cell and bispecific T cell engager therapies, where repetitive stimulation impairs T cell persistence and function, and allogeneic hematopoietic cell transplantation, where donor T cell exhaustion may influence graft-versus-host disease and graft-versus-leukemia activity. This review summarizes the mechanisms and clinical significance of T cell exhaustion across solid and hematologic malignancies and how exhaustion state shapes therapeutic response.
    Keywords:   T cell exhaustion; Bispecific T cell engagers; CAR T cell; Hematopoietic cell transplantation; Immune checkpoint blockade
    DOI:  https://doi.org/10.1007/s12185-026-04304-0
  2. Cancer Immunol Immunother. 2026 Aug 06. pii: 269. [Epub ahead of print]75(11):
       BACKGROUND: The physical microenvironment of solid tumors exerts compressive forces on cancer cells, but how such mechanical stress contributes to melanoma immune evasion remains largely unknown. This study investigates whether compression-induced nuclear deformation and metabolic reprogramming facilitate immune escape and explores the regulatory role of microphthalmia-associated transcription factor (MITF).
    METHODS: A three-dimensional (3D) melanoma spheroid model was established and subjected to microfluidic-based compressive stress. Nuclear morphology and cellular stiffness were evaluated using confocal microscopy and atomic force microscopy. Transcriptome sequencing and The Cancer Genome Atlas Skin Cutaneous Melanoma (TCGA-SKCM) transcriptomic analyses, together with differentially expressed gene (DEG) analysis, Gene Set Enrichment Analysis (GSEA), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, Seahorse metabolic assays, and flow cytometry, were used to identify key metabolic pathways and evaluate cluster of differentiation 8-positive (CD8+) T cell and natural killer (NK) cell function. MITF was silenced via lentiviral short hairpin RNA (shRNA) to determine its functional involvement.
    RESULTS: Squeezing (Sqz) treatment triggered marked nuclear elongation, reduced cellular stiffness, and enhanced both mitochondrial oxidative phosphorylation and glycolysis in melanoma cells. These metabolic alterations were accompanied by impaired interferon-gamma (IFN-gamma) and Granzyme B production in CD8+ T cells and reduced NK cell effector activity, together with increased immune cell apoptosis. Public TCGA-SKCM analyses further supported an association between high MITF expression, reduced cytotoxic immune signatures, lower immune infiltration, and MITF-related metabolic pathway enrichment. MITF knockdown attenuated nuclear deformation, suppressed metabolic overactivation, restored mitochondrial membrane potential, and rescued CD8+ T cell- and NK cell-mediated cytotoxicity.
    CONCLUSION: Sqz-induced metabolic alterations in melanoma cells are accompanied by impaired CD8+ T cell and NK cell antitumor effector functions. MITF may act as an important molecular link connecting nuclear mechanotransduction, metabolic reprogramming, and immune escape, suggesting a potential strategy for counteracting physical stress-driven immunosuppression.
    Keywords:  Compression; MITF; Melanoma; Metabolic reprogramming; Nuclear deformation; Tumor microenvironment
    DOI:  https://doi.org/10.1007/s00262-026-04495-9
  3. Mol Cancer. 2026 08 06. pii: 264. [Epub ahead of print]25(1):
      T cell exhaustion has traditionally been defined as a state of progressive functional impairment and specific epigenetic remodeling induced by chronic antigen stimulation. However, emerging multidisciplinary evidence indicates that exhaustion is not merely a terminal stage of functional failure; rather, it represents an evolutionarily conserved adaptive program designed to balance long-term immune surveillance with the limitation of excessive pathological damage. This review focuses on the positive regulatory roles of T cell exhaustion within the tumor microenvironment. It elucidates how the exhausted state avoids lethal inflammation by restraining excessive activation while preserving a durable progenitor pool, thereby ultimately establishing a homeostatic balance between sustained tumor control and host survival. Overall, a comprehensive understanding of the evolutionary principles underlying this adaptive program provides important guidance for the design of precision immunotherapies that balance efficacy and safety. Strategically targeting and harnessing these protective features may greatly optimize the clinical benefits of solid tumor treatment and guide the development of next-generation innovative immunotherapies.
    Keywords:  Adaptive differentiation; Immune homeostasis; Progenitor exhausted T cells; T cell exhaustion; Tumor microenvironment
    DOI:  https://doi.org/10.1186/s12943-026-02767-7
  4. J Clin Invest. 2026 Nov 05. pii: e202874. [Epub ahead of print]
      Deciphering immune privilege at the maternal-fetal interface is essential for understanding how reproductive success and host defense are simultaneously maintained. Decidualization, occurring within the specialized stromal tissue encapsulating the fetus and placenta, shapes local immune adaptation required for healthy pregnancy. Here, we identify a decidua-enriched effector-like memory CD8+ T cell subset marked by CD45RA in humans and CX3CR1 in mice. These cells preferentially accumulate in the decidua, which harbors a CX3CL1-dominant chemokine niche, and disruption of Cx3cr1 or uterine Cx3cl1 impaired their decidual recruitment and tissue localization. Human CD45RA+ and murine CX3CR1+ decidual memory CD8+ T cells shared conserved transcriptional and functional features, including enhanced cytotoxic potential and limited inflammatory cytokine production. Functionally, CX3CL1-mediated CD8+ T cell accumulation improved local control of prenatal Listeria monocytogenes infection and reduced infection-associated fetal loss. In contrast, fetal antigen-specific CD8+ T cell accumulation and fetal resorption occurred independently of uterine CX3CL1. Together, our findings define the maternal-fetal interface as an active immunological gatekeeper, that compartmentalizing CD8+ T cell-mediated antimicrobial adaptive immunity through the conserved CX3CL1-CX3CR1 axis, supporting pathogen-specific defense while preserving fetal tolerance.
    Keywords:  Adaptive immunity; Cellular immune response; Chemokines; Immunology; Reproductive biology
    DOI:  https://doi.org/10.1172/JCI202874
  5. Int J Mol Med. 2026 Dec;pii: 367. [Epub ahead of print]58(6):
      S‑palmitoylation is a critical post‑translational regulator of protein function; however, its role in T cell‑mediated antitumor immunity remains unclear. The present review summarizes emerging evidence that redefines T cell biology and its implications for antitumor immunity. The regulatory functions of S‑palmitoylation in T cell receptor signaling, activation, proliferation, differentiation, exhaustion and apoptosis are first outlined, highlighting the distinct roles of the zinc finger Asp‑His‑His‑Cystype family of palmitoyl acyltransferases and depalmitoylating enzymes in modulating the membrane localization, stability and signal transduction of key T cell signaling regulators. How S‑palmitoylation of immune checkpoints, such as programmed death‑ligand 1, and the components of antigen presentation shape the tumor immune microenvironment were further examined. Additionally, the recent advances in therapeutic strategies targeting S‑palmitoylation, including small‑molecule inhibitors, peptide‑based interventions and nanoparticle delivery systems, were highlighted, and their potential to enhance T cell antitumor immunity, particularly in combination with immune checkpoint blockade, was discussed. Finally, the current challenges, including the suboptimal selectivity of pharmacological agents, technical limitations of existing delivery systems and the intrinsic heterogeneity and immunosuppressive nature of the tumor microenvironment were discussed, and future directions for advancing S‑palmitoylation‑targeted immunotherapies were proposed. Collectively, the present review highlights S‑palmitoylation as a promising regulatory axis for antitumor immunity and provides a foundation for the future development of targeted immunotherapies.
    Keywords:  S‑palmitoylation; T cell; antitumor immunity; immune checkpoint; targeted therapy
    DOI:  https://doi.org/10.3892/ijmm.2026.6038
  6. Cell Stem Cell. 2026 Nov 04. pii: S1934-5909(26)00388-7. [Epub ahead of print]
      The perivascular (Pv) niche coordinates immune-stromal interactions that facilitate cancer progression. Pharmacological inhibition or genetic inactivation of the enzyme heme oxygenase-1 (HO-1) in LYVE-1+ Pv tumor-associated macrophages (PvTAMs) synergizes with cytotoxic chemotherapy (CCT) to achieve immunological tumor control in murine breast cancer models. We investigated the tumor microenvironment (TME) during the transition to immunological control and identified an increase in stem-like TCF1+PD-1+CD8+ T cells and enrichment of tumor-selective effector T cells. Stem-like CD8+ T cells were clonally diverse and rapidly acquired a TCF1- differentiated phenotype in the TME. Their tumor accumulation depended on CXCR4 and was associated with a treatment-induced expansion of proliferating CXCL12+CD34+ Pv cancer-associated fibroblasts (CAFs). In human breast cancer, greater abundance of the stem-like CD8+ T cell program was associated with improved outcomes following CCT. These findings identify PvTAM HO-1 activity as a regulator of a stromal-stem-like T cell axis that limits chemotherapy efficacy and anti-tumor immunity.
    Keywords:  CAF; CXCL12; CXCR4; chemotherapy and cancer; heme oxygenase-1; macrophage; perivascular; stem-like CD8(+) T cells; tumor microenvironment
    DOI:  https://doi.org/10.1016/j.stem.2026.10.007
  7. Nat Commun. 2026 Oct 07. pii: 11431. [Epub ahead of print]17(1):
      Interleukin 2 (IL2) promotes T cell proliferation and differentiation, making it a central target in immunotherapies. Following antigen recognition, IL2 receptor (IL2R) signaling polarizes towards the immunological synapse (IS). However, how IL2 function is integrated during earlier antigen-dependent T cell synapses remains unknown. Here, we employ a supported-lipid bilayer system and TIRF microscopy to monitor the IL2R subunits and their spatiotemporal organization relative to T cell receptor (TCR) at the IS of CD8+ T cells. We show that TCR and IL2 signaling overlap in space and time and synergize when simultaneously triggered. Using Immuno-STATs, a class of immunotherapeutics in clinical testing that co-deliver IL2 and peptide major histocompatibility complex (pMHC), we demonstrate synergistic TCR and IL2R signaling that drives efficient expansion of antigen-specific CD8+ T cells. Together, these findings establish the IS as a platform for coordinated cytokine and antigen receptor signaling, providing a mechanistic framework for more selective antigen-specific immunotherapies.
    DOI:  https://doi.org/10.1038/s41467-026-77110-1
  8. Immunotherapy. 2026 Oct 31. 1-13
       BACKGROUND: Tumor progression in lung adenocarcinoma (LUAD) is critically mediated by immune escape mechanisms. MAP7D2 was found to be upregulated in LUAD and associated with poor prognosis; however, its functional role in LUAD remains elusive.
    METHODS: Stable MAP7D2-knockdown cell lines were generated via lentiviral delivery of shRNA in human LUAD cell lines (A549 and NCI-H1648) and murine Lewis lung carcinoma cells. Immunocompetent syngeneic mouse models were established to evaluate the impact of MAP7D2 deficiency on tumor growth and antitumor immunity.
    RESULTS: MAP7D2 silencing did not alter the intrinsic proliferative capacity or clonogenic potential of A549 and NCI-H1648 cells in vitro. Additionally, co-culture assays demonstrated that MAP7D2 knockdown in LLC cells significantly potentiated CD8+ T cell-mediated cytotoxicity. Concordantly, CD8+ T cells exhibited elevated IFN-γ expression and diminished PD-1/TIGIT expression, consistent with augmented effector function. In immunocompetent syngeneic mouse models, MAP7D2 knockdown significantly inhibited LLC tumor growth, which was mechanistically linked to increased intratumoral infiltration of CD8+ cytotoxic T lymphocytes. Mechanistically, the effects of MAP7D2 overexpression were reversed by HMGB1, restoring CD8+ T cell cytotoxicity.
    CONCLUSION: MAP7D2 knockdown inhibited the growth and development of LUAD by increasing the infiltration of CD8+ T lymphocytes, thereby enhancing antitumor immunity.
    Keywords:  HMGB1; LUAD; MAP7D2; cytotoxic T lymphocytes; immunotherapy
    DOI:  https://doi.org/10.1080/1750743X.2026.2755173